Recognitions
NPCB:
Stempeutics Malaysia gets NPCB (National Pharmaceutical Control Bureau, Malaysia) approval for Good Manufacturing Practices (GMP) in accordance to the current Pharmaceutical Inspection Co-operation Scheme (PIC/S) GMP Guides and its relevant Annexes for Isolation, Processing and Storage of Mesenchymal Stem Cells.
ISO 9001:2008
Stempeutics Research Manipal has been awarded ISO 9001:2008 certification for "Development and Processing of Stem Cells for Clinical Trials" by TUV Rheinland in April 2010
Stempeutics is the first international company in Malaysia to get the BioNexus status by Malaysian Biotechnology Corporation SDN BHD.
Datuk Iskandar Mizal Mahmood, CEO of Malaysian Biotechnology Corporation Sdn Bhd, said he was pleased with the Manipal Group's commitment to develop Malaysia as a stem cell research and therapy hub and stated "This commitment will help to build a strong human resource foundation in Malaysia for all the stem cell industry and research institutes." [What is BioNexus Status?]
DSIR
Stempeutics Bangalore and Manipal R&D units have been recognised by Department of Scientific and Industrial Research (DSIR)
‘Stempeutics – one of India’s ten hottest start ups in 2008”
Business Today, 18th May 2008 [Click here to read the article]
ICMR
Stempeutics stem cell research centre at Bangalore has been approved by Indian Council of Medical Research for Stem Cell Research activities.
Bio Malaysia
At the Bio Malaysia, Stempeutics' innovations were shortlisted for the "achievement area" display among the exhibitors. [View Display 1] [View Display 2]
Awards & Selections
Our scientist was awarded the Department of Biotechnology (DBT) – Government of India, Overseas Associate-ship for Niche Areas in Biotechnology.
Our Scientist was selected for the Indian National Science Academy (INSA) Bilateral Exchange Program with Czech Republic.
|
